Form 4 for PRVA Privia Health Group, Inc.
Accepted 2026-05-05 20:07:19 ET · period of report 2026-05-01 · accession 0001858396-26-000009 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-05-05 20:07 | 2026-05-01+ | PRVA | Mountcastle David | EVP, CFO | M - OptEx | $2.00 | +8,385 | 216.1K | +4% | +$16.8K |
| DMT | 2026-05-05 20:07 | 2026-05-01+ | PRVA | Mountcastle David | EVP, CFO | S - Sale+OE | $25.03 | -8,385 | 214.8K | -4% | -$209.8K |
| DMT | 2026-05-05 20:07 | 2026-05-01+ | PRVA | Mountcastle David | EVP, CFO | M - OptEx | $0.00 | -8,385 | 5,962 | -58% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.01 per share | 2026-05-01 | M | A | 7,179 | $2.00 | 222,026 | D | — | — | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. |
| 2 | Common | Common Stock, par value $0.01 per share | 2026-05-01 | S | D | 7,179 | $25.03 | 214,847 | D | — | — | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. (F2) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.20 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. |
| 3 | Common | Common Stock, par value $0.01 per share | 2026-05-04 | M | A | 1,206 | $2.00 | 216,053 | D | — | — | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. |
| 4 | Common | Common Stock, par value $0.01 per share | 2026-05-04 | S | D | 1,206 | $25.00 | 214,847 | D | — | — | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. |
| 5 | Derivative | Stock Option (Right to Purchase) | 2026-05-01 | M | D | 1,297 | $0.00 | 1,538 | D | $2.00 · — to 2029-12-03 | 1,297 Common Stock, par value $0.01 per share | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. (F3) All of the stock options are fully vested and exercisable. |
| 6 | Derivative | Stock Option (Right to Purchase) | 2026-05-01 | M | D | 541 | $0.00 | 1,053 | D | $2.00 · — to 2030-09-07 | 541 Common Stock, par value $0.01 per share | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. (F3) All of the stock options are fully vested and exercisable. |
| 7 | Derivative | Stock Option (Right to Purchase) | 2026-05-01 | M | D | 3,010 | $0.00 | 9,489 | D | $2.00 · — to 2028-08-27 | 3,010 Common Stock, par value $0.01 per share | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. (F3) All of the stock options are fully vested and exercisable. |
| 8 | Derivative | Stock Option (Right to Purchase) | 2026-05-01 | M | D | 2,331 | $0.00 | 6,322 | D | $2.00 · — to 2029-03-20 | 2,331 Common Stock, par value $0.01 per share | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. (F3) All of the stock options are fully vested and exercisable. |
| 9 | Derivative | Stock Option (Right to Purchase) | 2026-05-04 | M | D | 202 | $0.00 | 1,336 | D | $2.00 · — to 2029-12-03 | 202 Common Stock, par value $0.01 per share | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. (F3) All of the stock options are fully vested and exercisable. |
| 10 | Derivative | Stock Option (Right to Purchase) | 2026-05-04 | M | D | 52 | $0.00 | 1,001 | D | $2.00 · — to 2030-09-07 | 52 Common Stock, par value $0.01 per share | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. (F3) All of the stock options are fully vested and exercisable. |
| 11 | Derivative | Stock Option (Right to Purchase) | 2026-05-04 | M | D | 592 | $0.00 | 8,897 | D | $2.00 · — to 2028-08-27 | 592 Common Stock, par value $0.01 per share | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. (F3) All of the stock options are fully vested and exercisable. |
| 12 | Derivative | Stock Option (Right to Purchase) | 2026-05-04 | M | D | 360 | $0.00 | 5,962 | D | $2.00 · — to 2029-03-20 | 360 Common Stock, par value $0.01 per share | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. (F3) All of the stock options are fully vested and exercisable. |